Literature DB >> 14927718

Effect of ACTH on thymic masses.

L J SOFFER, J L GABRILOVE, B S WOLF.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; MYASTHENIA GRAVIS/complications; THYMUS/effect of drugs on

Mesh:

Substances:

Year:  1952        PMID: 14927718     DOI: 10.1210/jcem-12-6-690

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Problems in the surgical management of thymic tumors.

Authors:  L SOUTTER; S SOMMERS; A S RELMAN; C P EMERSON
Journal:  Ann Surg       Date:  1957-09       Impact factor: 12.969

2.  Neuroendocrine carcinoma presenting as cardiac tamponade and dramatic response to steroids.

Authors:  Lakshmi Meenakshisundaram; Julia Smith; Beatrice Deshommes
Journal:  BMJ Case Rep       Date:  2011-03-03

3.  Glucocorticoids induce G1 cell cycle arrest in human neoplastic thymic epithelial cells.

Authors:  Yasunobu Funakoshi; Hiroyuki Shiono; Masayoshi Inoue; Yoshihisa Kadota; Mitsunori Ohta; Hikaru Matsuda; Meinoshin Okumura; Tadaaki Eimoto
Journal:  J Cancer Res Clin Oncol       Date:  2005-02-10       Impact factor: 4.553

Review 4.  Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review.

Authors:  Ewa Wrona; Sylwia Dębska-Szmich; Marta Pastuszka; Marcin Braun; Rafał Czyżykowski; Piotr Potemski
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

5.  Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.

Authors:  Lukas Kirzinger; Sandra Boy; Jörg Marienhagen; Gerhard Schuierer; Reiner Neu; Michael Ried; Hans-Stefan Hofmann; Karsten Wiebe; Philipp Ströbel; Christoph May; Julia Kleylein-Sohn; Claudia Baierlein; Ulrich Bogdahn; Alexander Marx; Berthold Schalke
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.